Related Experiment Videos

Elevated serum parathormone levels are associated with myocardial iron overload in patients with beta-thalassaemia

Meropi Dimitriadou1, Athanasios Christoforidis, Marina Economou

  • 11st Paediatric Department, Aristotle University of Thessaloniki, Greece.

European Journal of Haematology
|September 12, 2009
PubMed

Insights

In beta-thalassaemia major patients, higher parathormone (PTH) levels predict increased myocardial iron overload. This finding highlights PTH as a key factor in heart complications for these patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Hematology

Background:

  • Beta-thalassaemia major patients face high mortality from iron-induced cardiomyopathy.
  • Myocardial iron overload is a significant complication in beta-thalassaemia major.
  • Previous research suggests a link between low vitamin D and increased myocardial iron.

Purpose of the Study:

  • To measure parathormone (PTH) and vitamin D metabolites in beta-thalassaemia major patients.
  • To investigate the relationship between these parameters and myocardial iron overload.
  • To identify predictors of cardiac complications in beta-thalassaemia major.

Main Methods:

  • Serum levels of intact parathormone (iPTH), 25(OH)D(3), and 1,25(OH)(2)D(3) were measured in 62 beta-thalassaemia major patients.
  • Myocardial iron content was assessed using magnetic resonance imaging.
  • Mean serum ferritin concentrations were calculated over the preceding year.

Main Results:

  • 60% of patients had decreased 25(OH)D(3) levels; 11% had borderline levels.
  • Patients with increased myocardial iron had significantly higher serum iPTH levels.
  • Multivariate regression analysis identified PTH as the major predictor of myocardial iron overload.

Conclusions:

  • Elevated parathormone (PTH) levels are strongly associated with increased myocardial iron in beta-thalassaemia major.
  • PTH may play a crucial role in the development of cardiac complications.
  • Monitoring PTH could be important for managing iron overload in these patients.
Abstract

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...